APELLIS PHARMACEUTICALS, INC.
Clinical trial NCT07020832 updates: 1. status: RECRUITING → SUSPENDED 2. start date: 2026-02-01 → 2026-05-18 3. completion date: 2028-08-01 → 2030-07-01 4. primary completion date: 2027-08-01 → 2029-06-01
Clinical trial NCT07020832 updates: 1. status: RECRUITING → SUSPENDED 2. start date: 2026-02-01 → 2026-05-18 3. completion date: 2028-08-01 → 2030-07-01 4. primary completion date: 2027-08-01 → 2029-06-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical